Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

The Effects of Riluzole and Trolox in Transient Retinal Ischemia

Kwon SI, Kim YE, Kim HC, Kim HK

  • KMID: 2206620
  • J Korean Ophthalmol Soc.
  • 2003 Mar;44(3):712-720.
PURPOSES: To evaluate the effect of riluzole (water soluble vitamin E, antioxidant) and trolox(glutamatergic neurotransmission antagonist) in transient retinal ischemia. METHODS: The effects of two drugs were investigated in a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes

Sala G, Arosio A, Conti E, Beretta S, Lunetta C, Riva N, Ferrarese , Tremolizzo L

OBJECTIVE: Until recently, riluzole was the only drug licensed for amyotrophic lateral sclerosis (ALS). In spite of its efficacy, the mechanism of action remains elusive, and both blocking of glutamate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Methylprednisolone and Riluzole on Axonal Growth after Acute Spinal Cord Injury in Rats

Hong CH, Yang JY, Lee JK, Song HS

  • KMID: 2336176
  • J Korean Orthop Assoc.
  • 2008 Dec;43(6):783-790.
PURPOSE: To determine the effect of methylprednisolone (MP) and riluzole administration on axonal growth after spinal cord injury (SCI) in rats. MATERIALS AND METHODS: Three Sprague Dawley rats (SD rat) served...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Update of Therapeutic Clinical Trials for Amyotrophic Lateral Sclerosis

Kim NH, Lee MO

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by progressive death of motor neurons in the cortex, brainstem, and spinal cord. Until now, many treatment strategies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rosmarinic Acid Alleviates Neurological Symptoms in the G93A-SOD1 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Seo JS, Choi J, Leem YH, Han PL

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons in the brain and spinal cord, resulting in paralysis of voluntary skeletal muscles and eventually death, usually within...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Halothane and Isoflurane on KCNK2 Transfected HEK-293 Cells

Shin WJ, Kim HJ, Shim JH, Jeon WJ, Cho SY, Yeom JH, Kim KH, Kim KS

BACKGROUND: According to the report that KCNK activity in transfected COS-7 and HEK-293 cells was modulated by volatile anesthetics and activation of KCNK channels by neuroprotectants, the importance of KCNK2...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Agonistforthe Control of Apotosis through the Study of Cytokine Expression after Spinal CordInjuryin Rats

Yang JY, Riew KD

Purpose: To analyze the cytokines that appear after a spinal cord injury in rats and to determine the agonists that regulate apoptosis. Materials and Methods: Sixty female Sprague-Dawley rats were anesthetized,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Psychopharmacotherapy in Bipolar Depression, Present and Future

Jeong JH, Woo YS, Bahk WM

  • KMID: 2287424
  • Korean J Psychopharmacol.
  • 2008 May;19(3):125-135.
This article reviews the characteristics and major pharmacological treatment modalities of bipolar depression, which is distinguished from unipolar depression by etiologic differences, symptomatic features, clinical courses, and treatment responses. Bipolar...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Enhanced Expression of TREK-1 Is Related with Chronic Constriction Injury of Neuropathic Pain Mouse Model in Dorsal Root Ganglion

Han HJ, Lee SW, Kim GT, Kim EJ, Kwon B, Kang D, Kim HJ, Seo KS

Neuropathic pain is a complex state showing increased pain response with dysfunctional inhibitory neurotransmission. The TREK family, one of the two pore domain K+ (K2P) channel subgroups were focused among...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr